Lora B. Kramer
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
- Sphingolipid Metabolism and Signaling
Papers in
-
- Cell death mechanisms and regulation 10
- Histone Deacetylase Inhibitors Research 8
- Protein Degradation and Inhibitors 4
- DNA Repair Mechanisms 3
- Hematology 13
- Multiple Myeloma Research and Treatments 6
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Steven Grant (26 shared papers)Yun Dai (19 shared papers)Paul Dent (17 shared papers)Shuang Chen (9 shared papers)Mohamed Rahmani (6 shared papers)W. David Jarvis (3 shared papers)Xin‐Yan Pei (7 shared papers)Robert Bittman (1 shared paper)
- Journals
- Blood (7 papers)Cancer Research (4 papers)Clinical Cancer Research (3 papers)Biochemical Pharmacology (3 papers)Molecular Pharmacology (3 papers)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Lora B. Kramer
34 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Hematology 223
- Molecular Biology 863
- Oncology 279
- Genetics 86
- Pharmacology 63
Countries citing papers authored by Lora B. Kramer
This map shows the geographic impact of Lora B. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora B. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora B. Kramer more than expected).
Fields of papers citing papers by Lora B. Kramer
This network shows the impact of papers produced by Lora B. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora B. Kramer. The network helps show where Lora B. Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lora B. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 130 | |
| 2 | 2004 | 115 | |
| 3 | 2008 | 84 | |
| 4 | 2011 | 73 | |
| 5 | 2004 | 73 | |
| 6 | 1997 | 71 | |
| 7 | 2008 | 70 | |
| 8 | 2011 | 58 | |
| 9 | 2012 | 46 | |
| 10 | 2009 | 44 | |
| 11 | 2006 | 39 | |
| 12 | 2011 | 36 | |
| 13 | 1995 | 33 | |
| 14 | 2011 | 33 | |
| 15 | 1992 | 32 | |
| 16 | 2009 | 28 | |
| 17 | 1996 | 26 | |
| 18 | Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia. | 2002 | 26 |
| 19 | 2014 | 25 | |
| 20 | 1988 | 25 |
About Lora B. Kramer
Lora B. Kramer is a scholar working on Molecular Biology, Hematology, Oncology, Organic Chemistry and Genetics, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), Histone Deacetylase Inhibitors Research (8 papers), Multiple Myeloma Research and Treatments (6 papers), Cancer-related Molecular Pathways (5 papers), Protein Degradation and Inhibitors (4 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Hematology (223 citations), Molecular Biology (863 citations), Oncology (279 citations), Genetics (86 citations) and Pharmacology (63 citations). Lora B. Kramer has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Steven Grant, Yun Dai, Paul Dent, Shuang Chen, Mohamed Rahmani, W. David Jarvis, Xin‐Yan Pei, Robert Bittman, Jorge A. Almenara and Heather Martin. Their work appears in journals such as Blood, Cancer Research, Clinical Cancer Research, Biochemical Pharmacology and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.